Professor Guo Peixuan – a recipient of Pfizer’s Distinguished Faculty Award – lectured at the Wuhan Institute of Virology: the Chinese Communist Party-run lab believed by many to be the epicenter of COVID-19.

Guo, an Ohio State University Professor, visited the lab on October 24th, 2016 to deliver a lecture entitled the “Discovery of a Third Type of Biomotor.”

The unearthed lecture follows the American pharmaceutical giant drastically increasing its lobbying efforts amidst the COVID-19 pandemic, appearing to be responsible for nationwide COVID-19 vaccine mandates.

The National Pulse can reveal a link between Pfizer and the Wuhan Institute of Virology, adding to the company’s existing conflicts of interest with mainstream media and big technology platforms. The Chinese lab’s manipulation of “killer” coronaviruses capable of “direct human infection” has led many intelligence and public health officials to believe it spawned COVID-19 with funds from Anthony Fauci’s National Institute of Allergy and Infectious Diseases.

“At the report meeting, Professor Guo Peixuan mainly introduced his research work on two aspects of the phi29 DNA assembly motor and the RNA nanotechnology derived from it,” summarized the Wuhan Institute of Virology’s website in reference to Guo’s 2016 visit.

The event synopsis explains how Guo’s lecture to Wuhan researchers focused primarily on RNA technology:

“Professor Guo introduced a series of application work around the phi29 molecular motor, such as the establishment of high-efficiency drug screening ideas, single-molecule sensing technology and a new generation of DNA sequencing technology. In addition, Professor Guo also focused on a series of pioneering work in RNA nanotechnology.”

“Professor Guo’s wonderful report triggered a heated discussion among teachers and students present, and the scene was lively. Finally, Director Chen Xinwen presented the “Ge Hong Forum” commemorative medal to Professor Guo on behalf of the Institute of Virology,” noted the lab.

Guo’s invitation to lecture at the Wuhan lab follows his receipt of Pfizer’s Distinguished Professor Award in 1995, as revealed in his professional bio.

Guo also serves as the Director of the Cancer Nanotechnology Platform Partnership Program, operated by two taxpayer-backed agencies including the Director of the National Institutes of Health (NIH).